Man Group plc Makes New $595,000 Investment in ICU Medical, Inc. $ICUI

Man Group plc purchased a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 4,057 shares of the medical instruments supplier’s stock, valued at approximately $595,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of ICUI. Maryland State Retirement & Pension System boosted its stake in ICU Medical by 2.0% during the fourth quarter. Maryland State Retirement & Pension System now owns 3,619 shares of the medical instruments supplier’s stock valued at $516,000 after buying an additional 70 shares in the last quarter. California Public Employees Retirement System raised its position in ICU Medical by 0.3% in the first quarter. California Public Employees Retirement System now owns 30,461 shares of the medical instruments supplier’s stock worth $3,934,000 after acquiring an additional 90 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its position in shares of ICU Medical by 1.8% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,631 shares of the medical instruments supplier’s stock valued at $803,000 after purchasing an additional 100 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of ICU Medical by 11.6% in the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 101 shares during the last quarter. Finally, Lido Advisors LLC grew its stake in shares of ICU Medical by 4.5% in the 4th quarter. Lido Advisors LLC now owns 2,479 shares of the medical instruments supplier’s stock worth $354,000 after purchasing an additional 106 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Raymond James Financial restated a “strong-buy” rating and set a $200.00 target price on shares of ICU Medical in a report on Friday, August 7th. Zacks Research downgraded ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Piper Sandler lifted their target price on ICU Medical from $163.00 to $195.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Sanford C. Bernstein lowered ICU Medical to a “market perform” rating in a research report on Monday, June 15th. Finally, KeyCorp upped their target price on ICU Medical from $164.00 to $182.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $192.80.

ICU Medical Stock Down 2.1%

Shares of ICU Medical stock opened at $166.29 on Friday. ICU Medical, Inc. has a 1 year low of $112.50 and a 1 year high of $192.85. The company has a market cap of $4.16 billion, a P/E ratio of 140.92, a P/E/G ratio of 2.15 and a beta of 0.75. The company has a current ratio of 2.43, a quick ratio of 1.21 and a debt-to-equity ratio of 0.56. The stock has a 50-day moving average price of $166.96 and a 200 day moving average price of $144.70.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.91 by $0.46. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The company had revenue of $547.88 million for the quarter, compared to the consensus estimate of $533.44 million. During the same quarter in the prior year, the company earned $2.10 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. As a group, analysts expect that ICU Medical, Inc. will post 7.19 EPS for the current fiscal year.

Insider Activity at ICU Medical

In related news, COO Christian Voigtlander sold 8,929 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $182.93, for a total transaction of $1,633,381.97. Following the completion of the sale, the chief operating officer directly owned 37,377 shares in the company, valued at approximately $6,837,374.61. This trade represents a 19.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ben Sousa sold 2,250 shares of ICU Medical stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $178.32, for a total value of $401,220.00. Following the sale, the insider directly owned 3,076 shares of the company’s stock, valued at approximately $548,512.32. The trade was a 42.25% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 21,830 shares of company stock worth $3,905,003. 2.10% of the stock is currently owned by company insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.